U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 56

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr6:30884970
GRCh38:
Chr6:30917193
VARS2C141Y, C281Y, C311YCombined oxidative phosphorylation defect type 20Uncertain significance
(May 25, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr6:30883557
GRCh38:
Chr6:30915780
VARS2M141fs, M171fsCombined oxidative phosphorylation defect type 20Pathogenic
(Aug 9, 2023)
criteria provided, single submitter
3.
GRCh37:
Chr6:30888840
GRCh38:
Chr6:30921063
VARS2Combined oxidative phosphorylation defect type 20Likely pathogenic
(Jul 28, 2023)
criteria provided, single submitter
4.
GRCh37:
Chr6:30893977
GRCh38:
Chr6:30926200
VARS2P1061L, P1091L, P921LCombined oxidative phosphorylation defect type 20Uncertain significance
(Nov 6, 2020)
criteria provided, single submitter
5.
GRCh37:
Chr6:30888162
GRCh38:
Chr6:30920385
VARS2W309*, W449*, W479*Combined oxidative phosphorylation defect type 20Conflicting interpretations of pathogenicity
(Aug 24, 2023)
criteria provided, conflicting interpretations
6.
GRCh37:
Chr6:30890952
GRCh38:
Chr6:30923175
LOC126859646, VARS2L613F, L753F, L783FCombined oxidative phosphorylation defect type 20Uncertain significance
(Jan 6, 2023)
criteria provided, single submitter
7.
GRCh37:
Chr6:30886684
GRCh38:
Chr6:30918907
VARS2R216*, R356*, R386*Combined oxidative phosphorylation defect type 20Likely pathogenic
(May 21, 2020)
criteria provided, single submitter
8.
GRCh37:
Chr6:30883640
GRCh38:
Chr6:30915863
VARS2R168C, R198C, R28Cnot provided, Combined oxidative phosphorylation defect type 20Uncertain significance
(Dec 2, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr6:30889033
GRCh38:
Chr6:30921256
VARS2W388*, W528*, W558*Combined oxidative phosphorylation defect type 20Likely pathogenic
(Oct 22, 2021)
criteria provided, single submitter
10.
GRCh37:
Chr6:30883641
GRCh38:
Chr6:30915864
VARS2R168H, R198H, R28HCombined oxidative phosphorylation defect type 20, not providedUncertain significance
(May 22, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr6:30889075
GRCh38:
Chr6:30921298
VARS2H402R, H542R, H572RCombined oxidative phosphorylation defect type 20Uncertain significance
(Jun 12, 2020)
criteria provided, single submitter
12.
GRCh37:
Chr6:30893069
GRCh38:
Chr6:30925292
VARS2E758*, E898*, E928*Combined oxidative phosphorylation defect type 20Likely pathogenic
(Jan 3, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr6:30887851
GRCh38:
Chr6:30920074
VARS2Combined oxidative phosphorylation defect type 20Uncertain significance
(Jan 3, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr6:30882594-30882600
GRCh38:
Chr6:30914817-30914823
VARS2P25fsCombined oxidative phosphorylation defect type 20Uncertain significance
(Feb 25, 2021)
criteria provided, single submitter
15.
GRCh37:
Chr6:30892253
GRCh38:
Chr6:30924476
VARS2E723D, E863D, E893Dnot provided, Combined oxidative phosphorylation defect type 20Conflicting interpretations of pathogenicity
(May 12, 2023)
criteria provided, conflicting interpretations
16.
GRCh37:
Chr6:30884719
GRCh38:
Chr6:30916942
VARS2C106R, C246R, C276RCombined oxidative phosphorylation defect type 20, not providedConflicting interpretations of pathogenicity
(Apr 12, 2022)
criteria provided, conflicting interpretations
17.
GRCh37:
Chr6:30893887
GRCh38:
Chr6:30926110
VARS2L891R, L1031R, L1061RInborn genetic diseases, not provided, Combined oxidative phosphorylation defect type 20
Uncertain significance
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr6:30893061
GRCh38:
Chr6:30925284
VARS2R755H, R925H, R895HCombined oxidative phosphorylation defect type 20Uncertain significance
(Jan 22, 2018)
criteria provided, single submitter
19.
GRCh37:
Chr6:30892288
GRCh38:
Chr6:30924511
VARS2P875L, P905L, P735LInborn genetic diseases, Combined oxidative phosphorylation defect type 20, not provided
Uncertain significance
(Sep 14, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr6:30882755
GRCh38:
Chr6:30914978
VARS2Q48E, Q78EInborn genetic diseases, Combined oxidative phosphorylation defect type 20Uncertain significance
(Jun 7, 2023)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr6:30890482
GRCh38:
Chr6:30922705
LOC126859646, VARS2Combined oxidative phosphorylation defect type 20Pathogenic
(Feb 1, 2018)
criteria provided, single submitter
22.
GRCh37:
Chr6:30890248
GRCh38:
Chr6:30922471
LOC126859646, VARS2R512W, R652W, R682WInborn genetic diseases, Combined oxidative phosphorylation defect type 20, not provided,
See cases
Uncertain significance
(Aug 9, 2023)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr6:30883986
GRCh38:
Chr6:30916209
VARS2R71W, R241W, R211WCombined oxidative phosphorylation defect type 20, not providedUncertain significance
(Sep 17, 2021)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr6:30883006
GRCh38:
Chr6:30915229
VARS2E122G, E92GCombined oxidative phosphorylation defect type 20, not providedUncertain significance
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr6:30893700
GRCh38:
Chr6:30925923
VARS2R862Q, R1032Q, R1002QCombined oxidative phosphorylation defect type 20, not providedUncertain significance
(Aug 21, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr6:30893396-30893397
GRCh38:
Chr6:30925619-30925620
VARS2L821fs, L991fs, L961fsCombined oxidative phosphorylation defect type 20Likely pathogenic
(Nov 15, 2019)
criteria provided, single submitter
27.
GRCh37:
Chr6:30892165
GRCh38:
Chr6:30924388
VARS2R834H, R694H, R864HCombined oxidative phosphorylation defect type 20Uncertain significance
(Mar 8, 2019)
criteria provided, single submitter
28.
GRCh37:
Chr6:30893135
GRCh38:
Chr6:30925358
VARS2Y780H, Y920H, Y950HCombined oxidative phosphorylation defect type 20Pathogenic
(Feb 22, 2021)
no assertion criteria provided
29.
GRCh37:
Chr6:30892129
GRCh38:
Chr6:30924352
VARS2Combined oxidative phosphorylation defect type 20, not providedPathogenic/Likely pathogenic
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr6:30886678
GRCh38:
Chr6:30918901
VARS2D384N, D214N, D354NCombined oxidative phosphorylation defect type 20Pathogenic
(Jul 9, 2020)
no assertion criteria provided
31.
GRCh37:
Chr6:30890717
GRCh38:
Chr6:30922940
LOC126859646, VARS2A747T, A577T, A717TCombined oxidative phosphorylation defect type 20Pathogenic
(Jul 9, 2020)
no assertion criteria provided
32.
GRCh37:
Chr6:30888447
GRCh38:
Chr6:30920670
VARS2R497H, R327H, R467HCombined oxidative phosphorylation defect type 20Uncertain significance
(Dec 19, 2018)
criteria provided, single submitter
33.
GRCh37:
Chr6:30888503
GRCh38:
Chr6:30920726
VARS2E516*, E346*, E486*Combined oxidative phosphorylation defect type 20, not provided, Inborn genetic diseases
Pathogenic/Likely pathogenic
(Sep 29, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr6:30889370
GRCh38:
Chr6:30921593
VARS2E406V, E546V, E576VCombined oxidative phosphorylation defect type 20Uncertain significance
(May 3, 2020)
criteria provided, single submitter
35.
GRCh37:
Chr6:30889424
GRCh38:
Chr6:30921647
VARS2A424V, A564V, A594Vnot specified, not provided, Combined oxidative phosphorylation defect type 20
Conflicting interpretations of pathogenicity
(Aug 10, 2023)
criteria provided, conflicting interpretations
36.
GRCh37:
Chr6:30889920-30889921
GRCh38:
Chr6:30922143-30922144
LOC126859646, VARS2L472fs, L612fs, L642fsCombined oxidative phosphorylation defect type 20Pathogenic/Likely pathogenic
(Mar 3, 2023)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr6:30883879-30883886
GRCh38:
Chr6:30916102-30916109
VARS2not provided, Combined oxidative phosphorylation defect type 20Benign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr6:30882717
GRCh38:
Chr6:30914940
VARS2H35R, H65RInborn genetic diseases, Combined oxidative phosphorylation defect type 20Uncertain significance
(Mar 23, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr6:30893715
GRCh38:
Chr6:30925938
VARS2Q1007R, Q1037R, Q867RCombined oxidative phosphorylation defect type 20, not providedUncertain significance
(May 12, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr6:30886590
GRCh38:
Chr6:30918813
VARS2Combined oxidative phosphorylation defect type 20Uncertain significance
(May 4, 2017)
criteria provided, single submitter
41.
GRCh37:
Chr6:30887868
GRCh38:
Chr6:30920091
VARS2A390T, A420T, A250TVARS2-related condition, Inborn genetic diseases, not provided,
See cases, Combined oxidative phosphorylation defect type 20
Conflicting interpretations of pathogenicity
(Nov 6, 2023)
criteria provided, conflicting interpretations
42.
GRCh37:
Chr6:30888508-30888510
GRCh38:
Chr6:30920731-30920733
VARS2G488del, G348del, G518delCombined oxidative phosphorylation defect type 20Likely pathogenic
(Nov 8, 2017)
criteria provided, single submitter
43.
GRCh37:
Chr6:30888447
GRCh38:
Chr6:30920670
VARS2R467P, R327P, R497PCombined oxidative phosphorylation defect type 20Likely pathogenic
(Nov 8, 2017)
criteria provided, single submitter
44.
GRCh37:
Chr6:30883762
GRCh38:
Chr6:30915985
VARS2R171W, R201W, R31WInborn genetic diseases, not provided, Combined oxidative phosphorylation defect type 20
Conflicting interpretations of pathogenicity
(Jan 1, 2023)
criteria provided, conflicting interpretations
45.
GRCh37:
Chr6:30892215
GRCh38:
Chr6:30924438
VARS2R851C, R881C, R711CCombined oxidative phosphorylation defect type 20, not providedConflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
46.
GRCh37:
Chr6:30893728
GRCh38:
Chr6:30925951
VARS2not specified, not provided, Combined oxidative phosphorylation defect type 20
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr6:30893127
GRCh38:
Chr6:30925350
VARS2R917Q, R947Q, R777QCombined oxidative phosphorylation defect type 20, not specified, not provided
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr6:30890871
GRCh38:
Chr6:30923094
LOC126859646, VARS2not specified, not provided, Combined oxidative phosphorylation defect type 20
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr6:30890483
GRCh38:
Chr6:30922706
LOC126859646, VARS2V680L, V710L, V540Lnot specified, not provided, Combined oxidative phosphorylation defect type 20
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr6:30888161
GRCh38:
Chr6:30920384
VARS2W449R, W479R, W309Rnot provided, not specified, Combined oxidative phosphorylation defect type 20
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr6:30887972
GRCh38:
Chr6:30920195
VARS2not specified, not provided, Combined oxidative phosphorylation defect type 20
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr6:30882203
GRCh38:
Chr6:30914426
VARS2not specified, not provided, Combined oxidative phosphorylation defect type 20
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr6:30889936
GRCh38:
Chr6:30922159
LOC126859646, VARS2T617M, T647M, T477Mnot specifiedUncertain significance
(Dec 15, 2016)
criteria provided, single submitter
54.
GRCh37:
Chr6:30886628
GRCh38:
Chr6:30918851
VARS2T367I, T337I, T197IInborn genetic diseases, Combined oxidative phosphorylation defect type 20, not provided
Pathogenic
(Jun 26, 2023)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr6:30889753
GRCh38:
Chr6:30921976
LOC126859646, VARS2A626D, A596D, A456DCombined oxidative phosphorylation defect type 20Pathogenic
(Jul 2, 2014)
no assertion criteria provided
56.
GRCh37:
Chr6:30886663
GRCh38:
Chr6:30918886
VARS2A379T, A349T, A209TCombined oxidative phosphorylation defect type 20Pathogenic
(Jul 2, 2014)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination